If there’s one thing that has always fascinated the human mind, it is genetic engineering. Since the advent of this tangible possibility, scientists and...
Scenic Biotech, a pioneer in the discovery of genetic modifiers developing therapeutics to treat severe diseases, announced positive preclinical data for its lead small...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Myeloid Therapeutics, Inc., a clinical stage oncology company, has appointed Matthew Maurer, M.D. as Chief Medical Officer. Dr. Maurer is an experienced physician-scientist with...
Immunitas Therapeutics, a clinical stage precision immunotherapy company committed to discovering and developing novel, differentiated therapeutics for patients with cancer, announced the appointment of...
